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Abstract
Induced pluripotent stem cells (iPSCs) share similar characteristics with ESCs of indefinite in
vitro growth, and may therefore serve as a useful tool for the targeted genetic modification of
farm animals via nuclear transfer (NT). Since derivation of stable ESC lines from farm
animals has not been possible, it is important to determine whether iPSCs can be used as
substitutes to ESCs for generating genetically modified cloned farm animals. We generated
ovine iPSCs by conventional retroviral transduction using the four Yamanaka factors. These
cells were bFGF- and Activin A-dependent, showed persistent expression of the transgenes,
acquired chromosomal abnormalities and failed to activate endogenous NANOG.
Nonetheless, iPSCs could differentiate into the three somatic germ layers in vitro. Since
cloning of farm animals is best achieved with diploid cells (G1/G0), we synchronized the
iPSCs in G1 prior to NT. Despite the cell cycle synchronization, preimplantation
development of iPS-NT embryos was lower than with somatic cells (2% vs 10% blastocysts,
p< 0.01). Furthermore, analysis of the blastocysts produced demonstrated persistent
expression of the transgenes, aberrant expression of endogenous SOX2, and a failure to
activate NANOG consistently. In contrast, gene expression in blastocysts produced with the
parental foetal fibroblasts was similar to those generated by in-vitro fertilization. Taken
together, our data suggest that the persistent expression of the exogenous factors and the
acquisition of chromosomal abnormalities are incompatible with normal development of NT
embryos produced with iPSCs.
Introduction
While embryonic stem cells (ESCs) can be derived from mouse and human blastocysts, ESCs
from farm animals have not yet been established. Instead, cells with similar properties can be
derived from fibroblast cells by forcing expression of exogenous reprogramming factors
(Takahashi and Yamanaka, 2006) to generate induced pluripotent stem cells (iPSCs).
Because iPSCs can self-renew long term in vitro and are amenable to complex genetic
modification, they represent a valuable alternative for the generation of transgenic animals
via nuclear transfer (NT).
Although iPSCs have been used to produce cloned mice by NT with equivalent success to
ESC donors (Kou et al., 2010; Zhou et al., 2010), a large joint effort failed to produce cloned
piglets using porcine iPSCs and successful term development was only obtained when iPSCs
were differentiated before using them as NT donors (Fan et al., 2013). It is not clear what
prevented postimplantation development of embryos reconstructed with undifferentiated
iPSCs, but it is possible that either the lack of cell cycle synchronization prior to NT or the
quality of the iPSCs compromised the developmental competence of those embryos.
Pluripotent cells (ESCs, iPSCs and blastomeres) have a shortened overall cell cycle length
with an extended S-phase. This means that using cycling cells as nuclear donors will result in
poor development, because S-phase donor cells are incompatible with normal development
after NT (Campbell and Alberio, 2003; Campbell et al., 1996a). Cloned farm animals are
commonly produced using donor differentiated cells arrested in G0/G1 of the cell cycle
(Campbell et al., 1996b; Kasinathan et al., 2001; Wells et al., 2003; Wilmut et al., 1997).
Although some reports show that G2/M donors can also be used (Lai et al., 2002; Lai et al.,
2001), other reports have found variable levels of aneuploidy and compromised development
of the resulting reconstructed embryos (Alberio et al., 2000; Yuan et al., 2014; Zhang et al.,
2004).
It is well accepted that NT with differentiated cells is very inefficient. In contrast, some
studies have reported higher cloning efficiencies (live offspring) with mouse ESCs (Eggan et
al., 2001; Jeanisch et al., 2002; Rideout et al., 2000; Wakayama et al., 1999). Despite higher
development to term, the preimplantation development of ESC-reconstructed embryos is
lower (15-29%) than embryos reconstructed with differentiated cells [40-67%, (Wakayama et
al., 1998; Wakayama et al., 1999; Wakayama and Yanagimachi, 1999)]. It is possible that the
lower preimplantation development of ESCs is due to lack of cell cycle synchronization
between donor cells and recipient cytoplasts prior to NT.
In this study, we evaluated whether cell cycle synchronization into G1 could improve
preimplantation development of NT embryos using ovine iPSCs compared to parental fetal
fibroblasts (PFFs). Reprogramming of key developmental genes (NANOG, SOX2, CDX2 and
GATA3) was analyzed in cloned blastocysts produced with iPSCs and PFFs as well as in
control in-vitro fertilization (IVF) blastocysts. We found that reprogramming of NANOG and
SOX2 was abnormal in iPS-NT blastocysts compared to IVF and PFF-NT blastocysts. In
addition, iPS-NT blastocysts showed persistent expression of the transgenes. Our data
suggest that the quality of ovine iPSCs, rather than cell cycle synchronization, is the crucial
factor determining normal embryo development after NT.
Materials and Methods
Generation of ovine iPSCs and culture of cells
The transfection of HEK (Human Embryonic Kidney) cells with individually packaged Oct4
(O), Sox2 (S), Klf4 (K) and c-Myc (M) viral vectors was performed as previously described
(Breton et al., 2013). Forty-eight hours after transfection, supernatants (6 ml) were collected
and filtered through 0.45 µm filters. Ovine parental foetal fibroblasts (PFFs; at passage four)
were seeded the day before onto a gelatine-coated 6-well plate at 2 x 105 cells/well and
transduced with 1ml of each of OSKM virus supplemented with 4 µg/ml Polybrene (Sigma).
The HEK cells were fed with 6ml fresh medium and the transduction was repeated 24 hours
later. Forty-eight hours after first transduction, transduced PFFs were passaged using 0.25%
trypsin-EDTA and seeded at 2 x 104 cells/well of a gelatine-coated 6-well feeder plate. Two
days later, the culture medium was changed to iPSC medium [knock-out DMEM (Life
Technologies) containing 20% knock-out serum replacement (Life Technologies), 2 mM
Glutamax (Gibco), 0.1 mM non-essential amino acids (NEAA; Life Technologies), 0.1 mM
2-mercaptoethanol (Life Technologies) and supplemented with either 10 ng/ml human basic
FGF (Peprotech)] and thereafter, the medium was changed daily. Transduced cells were
passaged after 7 days and plated onto 6-well feeder plates at 5 x 103 cells per well. iPSC
colonies were picked as they appeared and transferred to gelatine-coated 24-well feeder
plates. iPSCs were split 1:2 every 2-3 days. For passaging the cells, 0.05% trypsin (Gibco)
was used. iPSCs were incubated at 39°C, 5% CO2, 5% O2 in a humid incubator. PFFs were
cultured in DMEM (Sigma) supplemented with 10% FBS, 2 mM Glutamax, 0.1 mM non-
essential amino acids, 0.1 mM 2-mercaptoethanol and incubated at 39°C, 5% CO2, 5% O2.
Mouse embryonic fibroblasts (MEFs) were cultured on 0.1% gelatine-coated flasks and
maintained in DMEM supplemented with 10% FBS and 2 mM L-Glutamine. Low passage
(<P4) MEF feeder cells were mitotically inactivated by 5 G ray gamma irradiation and seeded
at 2 x 105 cells/well of a 6-well plate.
In-Vitro Differentiation
To test the ability of the clones to differentiate into the 3 germ layers (endoderm, ectoderm
and mesoderm), we allowed the cells to form embryoid bodies (EBs) and then differentiate.
iPSCs were passaged with collagenase and transferred onto bacterial grade non-adherent petri
dishes without any feeder layer, fed with 2ml of fresh iPSC medium and incubated at 37°C
and 5% CO2 overnight. The next day, the growing cells were transferred to a centrifuge tube
and allowed to settle down by gravity for 20 minutes. The media was changed to 6 ml
differentiation medium per tube (80% KO-DMEM, 10% FCS, 1x NEAA, 2mM L-Glutamine
and 0.1 mM β-mercaptoethanol). Following the media change, the cells were then transferred 
to fresh petri dishes and incubated under the same conditions as before. The media was
changed every two days until day 10. On day 11, EBs were transferred to two gelatin-coated
wells of a 24-well tissue culture plate. The now differentiating EBs were fed with fresh media
every day. On day 19, five wells of each plate were fixed with 4% paraformaldehyde (PFA).
The cells were stored in 70% ethanol at 7°C for immunocytochemistry. Images illustrating
EBs were recorded using a brightfield microscopy.
Colony formation assay
To assess self-renewal and proliferation abilities of iPSCs under different treatments, a
colony formation assay was carried out. A 24-well plate (Nunc) was treated with 0.1%
gelatine, MEFs were seeded at 6 x 104 cells/well and iPSCs were then seeded at 2000
cells/well. To block FGF receptors (FGFRs), MEK and ALK5 receptors, the following
pharmacological inhibitors (from Tocris bioscience) were used: PD173074 (100 nM),
PD0325901 (400 nM) and SB431542 (20 µM), respectively. The media was changed every
day and cells were allowed to grow for ten days. Cells were then stained for alkaline
phosphatase (AP) activity with the Leukocyte Alkaline Phosphatase Kit (Sigma) according to
the manufacturer’s instructions. Pictures were taken under bright field microscopy.
Immunofluorescence staining
Cells were fixed with 4% PFA and incubated with a blocking/permeabilization buffer (0.3%
Triton-X, 10% bovine serum albumin and 10% goat serum in phosphate-buffered saline
[PBS]). Cells were then incubated with primary antibody overnight at 4°C. Cells were then
rinsed three times in PBS and incubated with secondary antibody for 1 h at RT. After rinsing
three times in PBS and counterstained with 300 ng/ml DAPI. A single wash was repeated and
cells were left in PBS. Cells were viewed under confocal microscopy. The following
antibodies were used: anti-cytokeratin (10 µg/ml, C2931, Sigma), anti-vimentin (10 µg/ml,
V6630, Sigma), anti-beta III tubulin (10 µg/ml, MAB1637, Millipore), anti-OCT4 (1:100, sc-
8628, Santa Cruz), anti-FGF2R (1:100, sc-122, Santa Cruz), anti-histone 3 phospho-serine 10
(1:500, ab32107, Abcam), anti-mouse IgG (R6393, Invitrogen) and anti-rabbit IgG (1:500,
711-025-152, Jackson Immunoresearch).
Cell cycle synchronization of iPSCs
To synchronize iPSCs, cultures were treated with 200 ng/ml of nocodazole (Sigma) for 16 h.
Cells were then released by washing with PBS and replacing with growth medium. To assess
the proportion of cells in S-phase (DNA synthesis) and M-phase prior and after
synchronization, the cells were first stained with the Click-iT EdU Imaging Kit (Invitrogen)
followed by immunostaining against the M-phase marker H3 phospho-serine 10, respectively.
Briefly, iPSCs were given an EdU pulse of 30 min, trypsinized, washed and resuspended in
PBS, transferred onto slides by cytospin at 190 rpm for 3 min, fixed in 4% PFA for 15 min at
RT and stored in PBS at 4C. The cells were then stained for EdU according to the
manufacturer's instructions and followed by immunofluorescence staining against the M-
phase marker as described above.
Reverse-transcribed polymerase chain reaction (RT-PCR)
Total RNA was extracted from blastocysts and cells using the Absolutely RNA Nanoprep Kit
(Agilent Technologies) and the RNeasy Mini Kit (Qiagen), respectively. Then, first strand
cDNA was synthesized with SuperScript™ III Reverse Transcriptase (Invitrogen). The
QIAGEN® Fast Cycling PCR kit was used to amplify target cDNA following the
manufacturer's instructions. Primers (table 1) were used at 300 nM. Amplification was
carried out in a Mastercycler pro instrument (Eppendorf) with the following program: 45
cycles (35 cycles for GAPDH) at 96 °C for 10 sec, 60 °C for 30 sec, and 68 °C for 30 sec,
with an initial activation step of 5 min at 95 °C and a final extension step at 72 °C for 1 min.
The PCR products were resolved in 1.5% agarose gels.
Chromosome spreads
To increase the number of mitotic cells, demecolcine (Wako) was added to a final
concentration of 0.1 ug/mL and incubated for 1 h. Cells were trypsinized, centrifuged at 250x
g for 4 min, resuspended in 5 mL ice-cold 0.56% KCl (added dropwise while mixing) and
incubated for 10 min at RT. Cells were then centrifuged and resuspended with 5 ml of ice-
cold fixative (3 parts of methanol to 1 part of glacial acetic acid) added dropwise while
vortexing at low speed. Cells were centrifuged, resuspended in 200 µL of fixative, dropped
onto slides (pre-chilled at -20C) and air-dried. DNA was stained with Fluoroshield/DAPI
mounting medium. Micrographs were taken with epifluorescence microscopy.
Oocyte maturation, NT and in vitro fertilization (IVF)
Ovine ovaries were collected from a local abattoir and transported to the laboratory in warm
phosphate-buffered saline (PBS). Using needle and syringe, medium-sized (2-4 mm) follicles
were aspirated. Cumulus-oocyte-complexes (COCs) with at least two layers of cumulus cells
were selected for maturation in in vitro maturation (IVM) medium (bicarbonate buffered
M199 medium [Gibco] supplemented with 10% heat-inactivated FBS, 0.05 U/ml FSH/LH
[Pluset], 1.0 µg/ml 17β-oestradiol, 50 µg/ml gentamycin, 0.9 mM sodium pyruvate and 0.1 
mM cysteamine). COCs were incubated in a humidified incubator at 39˚C and 5% CO2 in air.
NT was performed as described previously (Choi et al., 2010; Lee et al., 2006). Briefly,
oocytes were denuded of cumulus cells at 14 h of maturation by treatment with hyaluronidase
(0.9 mg/ml, Sigma) and gentle pipetting. Oocytes with extruding spindles at anaphase
I/telophase I (AI/TI) were selected for enucleation. These oocytes were incubated in 10 µg/ml
Hoechst 33342 and 7.5 µg/ml cytochalasin B in IVM medium for 5 min and enucleations
were carried out in calcium-free HEPES buffered synthetic oviduct fluid (hSOF) with 7.5
µg/ml cytochalasin B using a micromanipulator. Enucleated oocytes were returned to IVM
medium containing 10 mM caffeine for 6 h until cell transfer. Since serum starvation caused
extensive cell death and differentiation in iPSCs, cells were first synchronized in M-phase
with 200 ng/ml nocodazole for 16 h and then in G1 by releasing the cells for 2 h in growth
medium without nocodazole. Cells were then collected by trypsinization and resuspended in
hSOF. The cells were kept at 4°C to slow down their metabolism and maintain cell cycle
synchrony. PFFs were synchronized in G0 by serum starvation for at least two days prior to
NT. For cell transfer, one cell was placed into the perivitelline space of each enucleated
oocyte and fused with one AC pulse of 1 V for 5 sec and two DC pulses of 100 V for 15 µs in
fusion medium (0.3M mannitol, 0.1 mM magnesium sulfate, 280 mOsm). Reconstructed
embryos were further cultured in IVM medium for 2 h. Embryos were then activated at 25-27
hpm in hSOF containing 5 µM calcium ionophore (A23187) and calcium ions for 5 min,
rinsed and incubated in SOF medium (7.3 mM sodium pyruvate, 0.20 mM L-glutamine, 25
mM sodium bicarbonate, 5.4 mM sodium lactate, 108 mM sodium chloride, 7.2 mM
potassium chloride, 1.2 mM potassium phosphate monobasic, 1.8 mM calcium chloride, 1.5
mM magnesium chloride, 0.34 mM tri-sodium-citrate, 2.8 mM myo-inositol, 10 µg/ml phenol
red, 0.1 mM essential and non-essential amino acids, 4 mg/ml free-fatty-acids BSA, pH 7.4
and 270-290 mOsm) containing 10 ug/ml cycloheximide and 7.5 µg/ml cytochalasin B for 5
h at 39˚C, 5% CO2 and 5% O2. Oocytes were then thoroughly rinsed and incubated in SOF.
Medium was changed at days 2 and 5 after.
For IVF, ram semen was incubated in 3 ml capacitation medium (0.33 mM sodium pyruvate,
1.0 mM L-glutamine, 4.0 mM sodium bicarbonate, 21 mM HEPES, 3.35 mM sodium lactate,
108 mM sodium chloride, 7.2 mM potassium chloride, 1.2 mM potassium phosphate
monobasic, 1.7 mM calcium chloride, 0.49 mM magnesium chloride, 2.4 mM glucose, 0.23
mM phenol red, 50 U/ml penicillin, 50 ng/ml streptomycin, pH 7.4 and 270-290 mOsm) for 1
h at 39 °C. Motile sperm was collected from the top 2 ml supernatant, centrifuged at 850g for
10 min at RT and resuspended in a small volume of IVF medium (2% FBS, 1.0 mM sodium
pyruvate, 1.0 mM L-glutamine, 25 mM sodium bicarbonate, 10 mM sodium lactate, 108 mM
sodium chloride, 7.2 mM potassium chloride, 1.2 mM potassium phosphate monobasic, 3.4
mM calcium chloride, 0.49 mM magnesium chloride, 1.4 mM phenol red, 50 U/ml penicillin,
50 ng/ml streptomycin, pH 7.9 and 270-290 mOsm). Matured COCs were incubated with 5
million sperm/ml in IVF medium for 20 h in a humidified incubator at 39˚C and 5% CO2 in
air. Presumptive zygotes were rinsed and cultured as described for NT.
Results
Characterization of bFGF/activin-dependent ovine iPSCs
The ovine iPSCs used in this study were generated by forced overexpression of the four
Yamanaka factors (Oct4, Sox2, c-Myc and Klf4) in ovine foetal fibroblasts using retroviral
transduction. These iPSCs displayed several characteristics associated with reprogramming
towards pluripotency including formation of compact colonies in culture (Fig. 1A),
downregulation of the fibroblast marker FSP1 and upregulation of endogenous SOX2 and
OCT4 (Fig.1 B), and positive AP staining (Fig. 1G). OCT4 was also detected by
immunostaining together with FGFR2, a receptor for bFGF (Fig. 1C). Surprisingly, iPSCs
were negative for NANOG (Fig. 1B). Expression of the trophectoderm (TE) markers GATA3
and CDX2 were not observed in either iPSCs or PFFs while they were detected in IVF
blastocysts (Fig. 1B). COL1A1, another gene highly expressed in fibroblasts, was also
expressed in iPSCs (Fig. 1B), but expression levels were 70 times higher in the PFFs as
estimated by quantitative RT-PCR (not shown). Ovine iPSC also expressed the exogenous
reprogramming factors (Fig. 1D). At passage 40, metaphase spread analysis of iPSCs
revealed that of the 50 spreads counted, all were diploid and 68% displayed a normal
karyotype with 54 chromosomes (Fig. 1E), with the remaining 32% showed a range of
aneuploidies (between 50 to 55 chromosomes). The parental cells had a normal karyotype.
Since bFGF was supplemented to the medium during the generation of these iPSCs and
subsequent culture, we wished to determine whether the iPSCs required bFGF for self-
renewal and proliferation. Furthermore, the cells were grown on a feeder layer of MEFs, a
source of Activin A that helps iPSCs maintain pluripotency by signalling through ALK
(Activin receptor-like kinase) receptors (Beattie et al., 2005). To study the FGF and Activin
A requirements of these iPSCs, we carried out a colony formation assay by seeding the cells
at low density and determined their AP activity after 10 days culture (Fig. 1G). Removing
bFGF from the medium reduced the number of colonies (38%, total) as well as their average
size (85%) relative to control (100%). Colony formation in bFGF-deprived medium was
further decreased by inhibiting MEK signalling (24%) and still further with double inhibition
of MEK and FGFRs (5%) relative to control. The size of bFGF-deprived iPSC colonies was
progressively reduced by FGFR inhibition (70%), MEK inhibition (58%), ALK5 receptor
inhibition (31%), FGF2R and MEK double inhibition (30%), and FGFRs and ALK5 double
inhibition (20%) relative to control. We further confirmed the Activin A requirements of
these iPSCs since they stained positive for the ectodermal marker beta III tubulin after
inhibition of ALK5 receptors for 10 days (Fig. 1 F). Taken together, this assay showed that
these ovine iPSCs required bFGF and that self-renewal and proliferation were regulated by
FGF/ERK together with Activin A signalling pathways.
To test whether these ovine iPSCs were pluripotent, we assessed their capacity to
differentiate in vitro into cell lineages derived from the three somatic germ layers. Under
conditions inducing differentiation (see Materials and Methods), the cells aggregated into
embryoid bodies and, after plating, they differentiated into cells positive for alpha-fetoprotein
(endoderm), vimentin (mesoderm) and beta III tubulin (ectoderm) (Fig. 2).
Cell cycle synchronization of ovine iPSCs
We used EDU labelling and anti phospho-histone H3 immunostaining to determine the cell
cycle profile of iPSCs. In continuous iPSCs cultures 40% of cells were in S-phase while 5%
were in mitosis, with the remaining 55% in G1 and G2. We first attempted to carry out NT
with cells that had been synchronized in M phase by a short block with demecolcine followed
by ‘shake off’ to release the mitotic cells (Kasinathan et al., 2001). This preliminary data
showed that development to blastocysts with M phase donors was very low, 4% for PFF-NT
and 0% for iPS-NT. Therefore, we opted to synchronize the iPSCs in G1 using nocodazole,
since synchronisation by serum starvation to G1/G0 resulted in extensive cell death and
differentiation. To this end, we synchronized the cells in M-phase by nocodazole block for 16
h and then released them (Fig. 3A-B). After 16 h block with 200 ng/ml of nocodazole, the
proportion of iPSCs in mitosis was enriched to 55%, while the proportion of cells in S-phase
was halved (20%). After 2 h release from nocodazole, these mitotic cells had progressed into
G1 since only 4% of cells remained in M and 9% were in S. iPSCs entered S-phase between 4
h and 6 h post-release, with about 66% of cells progressing from G1 to S phase between 4 h
and 10 h post-release (Fig. 3A-B). These data show that the proportion of ovine iPSCs in G1
can be enriched by nocodazole block and release. After 2 h release, we selected small iPSCs
as presumptive G1 donors for NT (Fig. 3C).
Ovine iPSCs produce fewer blastocysts than PFFs after NT
After synchronization of iPSCs in G1 and of PFFs in G0 prior to NT, we determined the
preimplantation development of the reconstructed embryos (table 2). Results from three
replicates show that cleavage rate was high in both groups (79% for iPS-NT and 90% for
PFF-NT), however blastocyst formation was significantly lower with iPS-NT (2%) compared
to PFF-NT (10%, p< 0.01, Chi square analysis).
iPSCs are not fully reprogrammed following NT
To assess nuclear reprogramming in reconstructed embryos with different donor cells, we
analysed the expression of NANOG, GATA3 and CDX2 at the blastocyst stage by endpoint
RT-PCR. We also included SOX2 in the analysis to determine whether this gene, which is
highly expressed gene in iPSCs, was downregulated in iPS-NT blastocysts. Analysis was
carried out in three biological replicates for both groups together with IVF controls (Fig. 4A).
We did not detect SOX2 in any of the IVF blastocysts, while expression was observed in 2/3
of replicates in iPS-NT blastocysts and 1/3 in PFF-NT blastocysts (Fig. 4B-C). The TE
markers GATA3 and CDX2 were consistently activated in all replicates (Fig. 4B).
Surprisingly, NANOG was not activated in 2/3 iPS-NT blastocysts, while IVF and PFF-NT
blastocysts activated this pluripotency gene in all three replicates (Fig. 4B-C).
We also investigated whether the exogenous pluripotency genes expressed in iPSCs were
silenced following NT. We found that all four exogenous genes were still expressed both at
the blastocyst stage and in embryos that failed to form blastocysts (Fig. 4D).
Discussion
In this study we investigated the growth characteristics and developmental capacity of bFGF-
dependent ovine iPSCs. We confirmed the dependency of these cells on bFGF and Activin A
signalling for self-renewal and proliferation, similar to the signalling requirement of hESC
and epiblast stem cells (Alberio et al., 2010; Brons et al., 2007; Tesar et al., 2007; Vallier et
al., 2005). However, in contrast to human ESCs and epiblasts stem cells, which form flat
colonies and usually do not tolerate passaging by trypsin, our ovine iPSCs formed dome-
shaped colonies and were passaged as single-cell suspensions. In this respect, ovine iPSCs
were more similar to mouse ESCs. These characteristics are consistent with ovine iPSCs
reported in previous studies (Bao et al., 2011; Liu et al., 2012; Sartori et al., 2012).
Nonetheless, using a colony formation assay, we showed that our ovine iPSCs were bFGF
and Activin A dependent. Removing bFGF from the culture medium resulted in fewer and
smaller colonies, and this was further confirmed using FGF/ERK signalling inhibitors.
Furthermore, inactivation of the ALK5 receptors with a specific inhibitor had a more
pronounced effect at reducing proliferation. This is consistent with previous reports showing
that the Activin A/Nodal pathway is required to maintain self-renewal of mouse epiblast stem
cells (Brons et al., 2007; Tesar et al., 2007) as well as pluripotency in pig epiblast stem cells
(Alberio et al., 2010; Park et al., 2013). Double inhibition of FGFRs and MEK or FGFRs and
ALK5 had a synergistic effect on proliferation compared to either inhibitor alone. Taken
together, these functional data support that both FGF/ERK and Activin A transduction
signalling pathways are important for self-renewal of ovine iPSCs.
Persistent expression of transgenes has been reported in iPSC lines from pigs (Esteban et al.,
2009; Ezashi et al., 2009; Fan et al., 2013; Rodriguez et al., 2012; West et al., 2010), cattle
(Sumer et al., 2011), mice (Okita et al., 2007), humans (Liu et al., 2009; Ramos-Mejia et al.,
2012), monkeys (Liu et al., 2008) and sheep (Sartori et al., 2012). Moreover, it appears that
overexpression of the transgenes is necessary to maintain pluripotency in iPSCs of farm
animals since differentiation has been reported following inactivation of the exogenous
factors in doxycycline (DOX) inducible systems (Bao et al., 2011; Hall et al., 2012; Li et al.,
2011, Rodriguez et al., 2012).
This continued dependency on expression of exogenous reprogramming factors suggests
incomplete activation of the network of endogenous genes associated with pluripotency.
Although both ovine studies involving DOX-inducible systems reported expression of
endogenous OCT4, SOX2 and NANOG (Bao et al., 2011; Li et al., 2011), it is possible that
other genes associated with pluripotency were not activated or that expression levels of
endogenous pluripotent genes were low and thus insufficient to maintain pluripotency
without expression of the transgenes. We found that endogenous OCT4 and SOX2 were
expressed while NANOG was not, suggesting incomplete reprogramming of the pluripotency
gene network. The lack of NANOG expression was consistent in multiple iPSC lines
generated (not shown). Although NANOG is essential for pluripotency in the embryo
(Chambers et al., 2003), recent evidence shows that iPSCs with full differentiation capacity
can be generated without Nanog (Carter et al., 2014; Schwarz et al., 2014), suggesting that
the four-factor overexpression system can bypass the requirement of Nanog during iPS
reprogramming. In agreement with these reports, ovine iPSCs were capable of differentiating
into cells derived from the three germ layers in vitro, demonstrating that they were
pluripotent. However, we found that NANOG reactivation was very limited in iPS cloned
blastocysts, suggesting that these iPSCs were locked in a reprogrammed state resistant to the
reprogramming machinery of the oocyte.
Despite the synchronization of iPSCs in G1, we found that development to blastocysts of
cloned embryos was not improved compared to those produced using fibroblasts. This
finding is consistent with a recent publication reporting similar developmental competence of
pig iPSCs and fibroblasts (Xie et al., 2014). While this manuscript was in preparation, a
report showed that iPSCs synchronized in G2/M are better suited for NT compared to G1 and
unsynchronized cells (Yuan et al., 2014). Improved development with G2/M synchronized
donors was also reported with mouse iPSCs (Kou et al., 2010). However, the general
observation with G2/M phase donors is that the resulting embryos have increased proportion
of aneuploidies, therefore, unlikely to support full term development.
We next sought to determine features of genetic reprogramming in cloned embryos produced
with different cell types. We found that blastocysts produced with PFFs are better
reprogrammed than those produced with iPSCs. NANOG, which was silent in both iPSCs and
PFFs, remained inactive in most iPS-NT blastocysts, while it was consistently expressed in
PFF-NT and IVF blastocysts. This was surprising since it was expected that a gene associated
with pluripotency would be activated more easily in iPSCs than in differentiated cells. SOX2,
in contrast, was not expressed in any of the IVF blastocysts, whereas it was expressed in 2/3
iPS-NT blastocysts and in 1/3 of PFF-NT blastocysts. This suggests that SOX2 was not
properly silenced following iPS-NT. It was surprising not to detect activation of SOX2 in IVF
blastocysts since we had previously detected low levels in control IVF blastocysts when
characterising gene expression of the cells (Fig. 1). One possibility for this incongruence is
that SOX2 starts to be expressed at this stage at low levels in some blastocysts, so it could be
detected in a pool of ten blastocysts (Fig. 1) but not in individual blastocysts (Fig. 4).
Alternatively, culture conditions might have affected gene expression as the IVF control
embryos used in Fig. 1 had been cultured with BSA while the ones in Fig. 4 were cultured
with FBS (as were the cloned embryos). As with endogenous SOX2, we observed no
silencing of exogenous pluripotency genes during preimplantation development of sheep iPS-
NT embryos, which is consistent with the recent publication in pigs (Xie et al., 2014).
Activation of trophectoderm lineage markers was normal as both iPS-NT and PPF-NT
blastocysts expressed CDX2 and GATA3. This is consistent with a previous study in mice,
which showed CDX2 expression in the trophectoderm of iPS-NT blastocysts by
immunocytochemistry (Kou et al., 2010). With the exception of the trophectoderm lineage,
our data support that genetic reprogramming in iPSCs is incomplete following NT. The
incomplete reprogramming of iPSCs after NT attests to the poor quality of iPS-NT embryos
and could explain the low development of cloned iPSCs embryos reported here and in a
previous study (Fan et al., 2013). To our knowledge, this is the first study comparing gene
expression reprogramming of key developmental genes between cloned blastocysts produced
with iPSCs versus parental fibroblast cells.
In summary, our data support that reprogramming of ovine iPSCs after NT is incomplete.
This might be an important factor explaining the low developmental capacity of reconstructed
embryos with iPSCs in farm animals. Persistent expression of transgenes and increased
number of aneuploidies in donor cells may be the reason for compromised reprogramming
and developmental potential NT embryos, although the underlying reason for these has yet to
be determined. Nonetheless, from our results in sheep and from those reported by other
groups in pigs (Fan et al., 2013; Xie et al., 2014), it is plausible to propose that iPSCs
generated by non-integrating methods (free of transgenes) would be better candidates for the
production of transgenic animals by NT.
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